Sampre Nutritions Ltd shareholders have overwhelmingly approved the appointment of Pradeep Narendra Poddar as a Non-Executive Non-Independent Director. The resolution, passed via postal ballot and remote e-voting concluding May 10, 2026, received near-unanimous support.
Out of 13,582,043 votes polled, an impressive 99.999% (13,581,902 votes) were cast in favour of Mr. Poddar's addition to the board. The company's paid-up equity share capital stands at ₹47.50 crore.
This strong shareholder backing signals confidence in enhancing the company's leadership and oversight. The appointment is standard under corporate practices, subject to retirement by rotation, and adds experienced guidance to Sampre Nutritions, a manufacturer of health supplements and nutraceuticals based in India.
While no specific risks were noted in the filing regarding this appointment, experienced directors are generally seen as valuable across the nutraceutical sector. Investors will likely monitor Mr. Poddar's contributions and how the board composition influences future company strategy.
The official voting results and the scrutinizer's report are expected to be made available on the company's website.
